Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Change in Acquisitions & Divestments (2023 - 2025)

Historic Change in Acquisitions & Divestments for Cytek Biosciences (CTKB) over the last 3 years, with Q3 2025 value amounting to $79.2 million.

  • Cytek Biosciences' Change in Acquisitions & Divestments rose 10842.11% to $79.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $261.1 million, marking a year-over-year increase of 2799.31%. This contributed to the annual value of $195.0 million for FY2024, which is 4772.73% up from last year.
  • Per Cytek Biosciences' latest filing, its Change in Acquisitions & Divestments stood at $79.2 million for Q3 2025, which was up 10842.11% from $66.5 million recorded in Q2 2025.
  • Over the past 5 years, Cytek Biosciences' Change in Acquisitions & Divestments peaked at $79.2 million during Q3 2025, and registered a low of $10.0 million during Q2 2023.
  • For the 3-year period, Cytek Biosciences' Change in Acquisitions & Divestments averaged around $54.3 million, with its median value being $60.2 million (2023).
  • Over the last 5 years, Cytek Biosciences' Change in Acquisitions & Divestments had its largest YoY gain of 30000.0% in 2024, and its largest YoY loss of 4411.76% in 2024.
  • Quarter analysis of 3 years shows Cytek Biosciences' Change in Acquisitions & Divestments stood at $54.0 million in 2023, then fell by 16.67% to $45.0 million in 2024, then skyrocketed by 76.0% to $79.2 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $79.2 million for Q3 2025, versus $66.5 million for Q2 2025 and $70.4 million for Q1 2025.